Universitätsklinikum Heidelberg

Hospital


Location: Heidelberg, Germany (DE) DE

ISNI: 0000000103284908

ROR: https://ror.org/013czdx64

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Valgus deformity of the distal tibia in children and adolescents with idiopathic flatfoot: Can it be predicted using 3D movement analysis? (2025) Dussa CU, Dostal N, Böhm H Journal article The prognostic relevance of pleural effusion in patients with COVID-19 - A German multicenter study (2025) Bucher AM, Dietz J, Ehrengut C, Müller L, Schramm D, Akinina A, Drechsel M, et al. Journal article Datennutzung für eine bessere Gesundheitsversorgung–Plädoyer für eine kooperative Forschungsdatenplattform der gesetzlichen und privaten Krankenversicherung und dem Netzwerk Universitätsmedizin (NUM) (2024) Schmitt J, Ihle P, Schoffer O, Reese JP, Ortmann S, Swart E, Hanß S, et al. Journal article Functional nanomaterials: Applications in medicine and life sciences (2024) Klein S, Kryschi M, Kryschi C Authored book Interactive exploration of adverse events and multimorbidity in CKD. (2024) Steinbrenner I, Kotsis F, Kosch R, Meiselbach H, Bärthlein B, Stockmann H, Lipovsek J, et al. Journal article Tailoring the Use of Central Pancreatectomy Through Prediction Models for Major Morbidity and Postoperative Diabetes: International Retrospective Multicenter Study (2024) Van Bodegraven EA, Lof S, Jones L, Aussilhou B, Yong G, Jishu W, Klotz R, et al. Journal article DNA Methylation Profiling of Salivary Gland Tumors Supports and Expands Conventional Classification (2024) Jurmeister P, Leitheiser M, Arnold A, Capilla EP, Mochmann LH, Zhdanovic Y, Schleich K, et al. Journal article Small cell transformation in EGFR-mutated non-small cell lung cancer: DLL3 expression and efficacy of immune checkpoint inhibitors or tyrosine kinase inhibitors combined with chemotherapy (2024) Saalfeld FC, Möller J, Christopoulos P, Wenzel C, Rasokat A, Wang XA, Vathiotis I, et al. Journal article The impact of physical activity on progression-free and overall survival in metastatic breast cancer based on molecular subtype (2024) Ziegler P, Hartkopf AD, Wallwiener M, Häberle L, Kolberg HC, Hadji P, Tesch H, et al. Journal article Physical activity levels are positively related to progression-free survival and reduced adverse events in advanced ER+ breast cancer (2024) Zimmer P, Esser T, Lueftner D, Schuetz F, Baumann FT, Rody A, Schneeweiss A, et al. Journal article